Studies in ovarian cancer cell cultures showed that the chemoresistance to some drugs such as cisplatin, the first platinum-based complex to treat patients with OC, is partly due to a deregulation of OPA1 processing [119], which results in an increase of mitochondrial fusion and decreased apoptosis [28]. This evidence concerns the gene OPA1 and ovarian cancer.